Pyxis Oncology (PYXS) to Acquire Apexigen (APGN) for $0.64/sh streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Apexigen, Inc. to Pyxis Oncology, Inc. for 0.1725 shares of Pyxis for each share of Apexigen is fair to Apexigen. | May 24, 2023
Pyxis Oncology to Acquire Apexigen Pyxis Oncology positioned at forefront of Antibody-Drug Conjugate development Commercially and clinically validated APXiMAB. | May 24, 2023
NEW YORK, May 24, 2023 /PRNewswire/ Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches. | June 11, 2023